Stockholders’ Equity (Details) - USD ($)									1 Months Ended	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 22, 2023	Jun. 21, 2023	May 19, 2023	Dec. 30, 2022	Sep. 13, 2022	Jul. 11, 2022	Oct. 22, 2021	Dec. 31, 2019	Aug. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Feb. 16, 2021
Stockholders’ Equity (Details) [Line Items]
Common stock authorized (in Shares)										750,000,000		750,000,000		750,000,000
Common stock par value (in Dollars per share)										$ 0.0001		$ 0.0001		$ 0.0001
Common stock issued (in Shares)										379,075,592		379,075,592		376,901,679
Common stock outstanding (in Shares)										379,075,592		379,075,592		376,901,679
Common stock conversion shares (in Shares)			2,173,913
Convertible debt			$ 25,000									$ 25,000
Expense										$ 0	$ 62,766	$ 0	125,532
Preferred stock, authorized (in Shares)										25,000,000		25,000,000		25,000,000
Preferred stock, par value (in Dollars per share)										$ 0.0001		$ 0.0001		$ 0.0001
Description of compensation service												(i) a cash endorsement fee of Three Hundred Thousand U.S. Dollars ($300,000 USD), payable as follows: (i) One Hundred Twenty-Five Thousand Dollars ($125,000) upon execution of the Endorsement Agreement, (ii) One Hundred Twenty-Five Thousand Dollars ($125,000) quarterly during the Term, beginning on the 90th day following the Effective Date, and (iii) Fifty Thousand Dollars ($50,000) on or prior to the first anniversary of the Effective Date and (ii) warrants exercisable for an aggregate of Fifteen Million (15,000,000) shares of the Common Stock at an exercise price of $0.0345 per share. The Warrants shall have a three-year term commencing from the Effective Date.
Shares of common stock (in Shares)										2,500		2,500			51,901,711
Expiration date									Aug. 30, 2027
Purchased shares (in Shares)								2,250,000
Exercise price (in Dollars per share)					$ 0.04
Note amendment transaction description				the Company entered into the December 2022 Note Amendment Transaction, as fully described in note 9 above. In terms of the Note Amendment Transaction the following occurred: ●The warrants issued to Cavalry and Mercer exercisable for 4,973,914 shares of Common Stock (2,486,957 for each of Cavalry and Mercer), were exchanged for two promissory notes of $482,000 each, as disclosed in note 8 above; ●The warrants issued to Cavalry and Mercer on August 30, 2022, were subject to repricing and a full rachet increase in the number of warrants issued, resulting in an increase in the number of warrants by 72,260,870 (36,130,435 to each Cavalry and Mercer) and a reset of the exercise price to $0.0115 per share. The additional warrants were valued at $841,003 using a Black-Scholes valuation model and was expensed in the statement of operations as a component of the loss on convertible debt. ●An additional 13,736,857 warrants previously issued to Mercer, Iroquois Master Fund and Bellridge Capital LP were subject to repricing of the exercise price from a range of $0.05 to $0.15 per share to $0.0115 per share. The change in the fair value of these warrants of $20,079, using a Black-Scholes valuation model was recorded as a component of the loss on convertible debt.
Limitation exceeds percentage												9.99%
Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears (in Dollars per share)	$ 0.015
Warrants outstanding an intrinsic value										$ 395,833	0	$ 395,833	0
Incentive stock options (in Shares)										198,926,452		198,926,452
Amount of immediate expense														$ 31,970
Options exercisable shares (in Shares)					200,000
Intrinsic value outstanding options										$ 0	0	$ 0	0
Option expense										$ 94,465	$ 94,462	$ 188,928	$ 188,928
Common Stock [Member]
Stockholders’ Equity (Details) [Line Items]
Common stock conversion shares (in Shares)										2,173,913
Shares of common stock (in Shares)									3,000,000
Exercise price (in Dollars per share)									$ 0.15
Exercise price (in Dollars per share)				$ 0.0115
Options exercisable shares (in Shares)					800,000
Warrant [Member]
Stockholders’ Equity (Details) [Line Items]
Purchased shares (in Shares)				30,000,000
Fair value of warrants				$ 348,938
Maximum [Member]
Stockholders’ Equity (Details) [Line Items]
Shares of common stock (in Shares)										800,000		800,000
Maximum [Member] | Common Stock [Member]
Stockholders’ Equity (Details) [Line Items]
Shares of common stock (in Shares)										100,000		100,000
Maximum [Member]
Stockholders’ Equity (Details) [Line Items]
Warrants beneficially percentage												4.99%
Chief Executive Officer [Member]
Stockholders’ Equity (Details) [Line Items]
Incentive stock options (in Shares)						15,000,000
Stock option exercise price (in Dollars per share)						$ 0.15
Amount of immediate expense														$ 823,854
Debt Conversion Notices [Member]
Stockholders’ Equity (Details) [Line Items]
Aggregate shares of common stock (in Shares)		66,335,391
Convertible debt amount		$ 0.0115
2021 Stock Incentive Plan [Member] | Maximum [Member]
Stockholders’ Equity (Details) [Line Items]
Shares of common stock (in Shares)							53,000,000
2018 Stock Incentive Plan [Member]
Stockholders’ Equity (Details) [Line Items]
Terminates period												10 years
2021 Stock Incentive Plan [Member]
Stockholders’ Equity (Details) [Line Items]
Terminates period							10 years